Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - Æxlishemjandi lyf - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metformin eql filmuhúðuð tafla 500 mg
eql pharma ab - metforminum hýdróklóríð - filmuhúðuð tafla - 500 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
procapen vet spenalyf, dreifa 3 g
animedica gmbh* - benzylpenicillinprocainum - spenalyf, dreifa - 3 g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
crinone leggangahlaup 8 %
merck ab - progesteronum inn - leggangahlaup - 8 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ovixan (ovison) húðlausn 1 mg/g
galenica ab - mometasonum fúróat - húðlausn - 1 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
oftan chlora augnsmyrsli 10 mg/g
santen oy* - chloramphenicolum inn - augnsmyrsli - 10 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ovixan (ovison) krem 1 mg/g
galenica ab - mometasonum fúróat - krem - 1 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
combisyn tafla 250 mg
norbrook laboratories (ireland) limited - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 250 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
malaseb vet. hársápa 2 % w/v
dechra veterinary products a/s* - chlorhexidinum díglúkónat; miconazolum nítrat - hársápa - 2 % w/v
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
noromectin (noromectin pour-on) áhella, lausn 0,5 % w/v
norbrook laboratories (ireland) limited - ivermectinum inn - Áhella, lausn - 0,5 % w/v